Events

EASL Congress 2025

Amsterdam, the Netherlands | May 7 - 10, 2025

HepQuant’s own Dr. Gregory T. Everson, CEO will present two posters at EASL Congress 2025 in Amsterdam, the Netherlands May 7 – 10. Top Poster #507 “Quantifying liver function by cholate clearance in extracorporeal circuits with a genetically modified porcine liver and brain-dead human decedent” and poster #355 “The HepQuant DuO test finds linkage between liver blood flow, portal-systemic shunting and cardiac hemodynamics in Fontan-associated liver disease”